| Line Item | 2024-07-31 | Y/Y |
|---|---|---|
| Revenue | $2.15B | +15.3% |
| Cost of Revenue | $324.1M | -2.4% |
| Gross Profit | $1.82B | +19.2% |
| R&D Expense | $639.0M | +10.0% |
| SG&A Expense | $200.9M | -13.5% |
| Operating Income | $7.6M | +103.7% |
| Pre-tax Income | -$101.3M | +56.6% |
| Income Tax | $23.5M | +11.8% |
| Net Income | -$124.8M |
| Line Item | 2024-07-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $655.3M | +27.8% |
| Accounts Receivable | $229.8M | +46.1% |
| Current Assets | $1.48B | -20.4% |
| Total Assets | $2.14B | -15.2% |
| Current Liabilities | $1.24B | +9.5% |
| Total Liabilities | $2.87B | -11.2% |
| Stockholders' Equity | -$728.1M | -2.9% |
| Line Item | 2024-07-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $672.9M | +147.0% |
| Capital Expenditures | $75.3M | +15.1% |
| Investing Cash Flow | $529.6M | +1163.8% |
| Financing Cash Flow | -$1.06B | -842.8% |
| Free Cash Flow | $597.7M | +188.7% |
| +51.0% |
| EPS (Basic) | -$0.51 | +53.2% |
| EPS (Diluted) | -$0.51 | +53.2% |